13F HOLDINGS REPORT
Euclidean Capital LLC
Quarter ended Q1 2025 · Filed May 15, 2025 · Accession 0001012975-25-000241
Total Value
$266.1M
Positions
11
Other Managers
0
Confidential Omitted
No
Holdings (11)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | ISHARES TR | 46429B598 | 2,425,144 | $124.8M | 46.91% |
| 2 | VANGUARD INTL EQUITY INDEX F | 922042775 | 1,991,884 | $120.8M | 45.40% |
| 3 | FOGHORN THERAPEUTICS INC | FHTX | 1,573,761 | $5.7M | 2.16% |
| 4 | ORIC PHARMACEUTICALS INC | ORIC | 989,410 | $5.5M | 2.07% |
| 5 | PMV PHARMACEUTICALS INC | PMVP | 2,627,643 | $2.9M | 1.08% |
| 6 | SPDR S&P 500 ETF TR | SPY | 4,104 | $2.3M | 0.86% |
| 7 | ALECTOR INC | ALEC | 1,307,858 | $1.6M | 0.60% |
| 8 | SURROZEN INC | SRZNW | 87,696 | $1.0M | 0.38% |
| 9 | RAPT THERAPEUTICS INC | 75382E109 | 657,899 | $802,637 | 0.30% |
| 10 | TENAYA THERAPEUTICS INC | TNYA | 1,015,705 | $579,053 | 0.22% |
| 11 | SURROZEN INC | SRZNW | 170,833 | $5,125 | 0.00% |